Business Description
Medlive Technology Co Ltd
ISIN : KYG5961B1041
Total Employee Number:
724Compare
Compare
Traded in other countries / regions
02192.Hong Kong1JZ.Germany IPO Date
2026-06-17Description
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 368.04 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | 312.91 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 15.02 | |||||
Beneish M-Score | -1.68 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26.5 | |||||
3-Year EBITDA Growth Rate | 37.8 | |||||
3-Year EPS without NRI Growth Rate | 39.9 | |||||
3-Year FCF Growth Rate | 19.7 | |||||
3-Year Book Growth Rate | 2.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 9.36 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 15.29 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67.71 | |||||
9-Day RSI | 63.35 | |||||
14-Day RSI | 63.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 19.09 | |||||
Quick Ratio | 19.09 | |||||
Cash Ratio | 17.79 | |||||
Days Sales Outstanding | 82.99 | |||||
Days Payable | 25.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 140.7 | |||||
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | 3.9 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 60.03 | |||||
Operating Margin % | 26.87 | |||||
Net Margin % | 52.08 | |||||
EBITDA Margin % | 59.49 | |||||
FCF Margin % | 18.96 | |||||
OCF Margin % | 20.95 | |||||
ROE % | 6.98 | |||||
ROA % | 6.59 | |||||
ROIC % | 14.75 | |||||
3-Year ROIIC % | 10.05 | |||||
ROC (Joel Greenblatt) % | 923.32 | |||||
ROCE % | 7.4 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.63 | |||||
Forward PE Ratio | 13.6 | |||||
PE Ratio without NRI | 16.15 | |||||
Price-to-Owner-Earnings | 17.69 | |||||
PEG Ratio | 0.5 | |||||
PS Ratio | 8.14 | |||||
PB Ratio | 1.07 | |||||
Price-to-Tangible-Book | 1.12 | |||||
Price-to-Free-Cash-Flow | 42.86 | |||||
Price-to-Operating-Cash-Flow | 38.81 | |||||
EV-to-EBIT | 3.89 | |||||
EV-to-EBITDA | 3.67 | |||||
EV-to-Revenue | 2.18 | |||||
EV-to-FCF | 11.52 | |||||
Price-to-GF-Value | 0.52 | |||||
Price-to-Projected-FCF | 1.04 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.64 | |||||
Price-to-Graham-Number | 0.9 | |||||
| Price-to-Net-Current-Asset-Value | 1.41 | |||||
| Price-to-Net-Cash | 1.51 | |||||
Earnings Yield (Greenblatt) % | 25.71 | |||||
FCF Yield % | 2.32 | |||||
Forward Rate of Return (Yacktman) % | 21.69 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medlive Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 77.705 | ||
| EPS (TTM) (€) | 0.055 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 63.15 | ||
| 14-Day ATR (€) | 0.014414 | ||
| 20-Day SMA (€) | 0.8166 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.698 - 0.861 | ||
| Shares Outstanding (Mil) | 739.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medlive Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medlive Technology Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| General meeting for 2025 | 2026-05-08 15:00 | -- | ||
| Annual report for 2025 | 2026-04-14 | -- | ||
| Second quarter earnings results for 2025 | 2025-08-27 | -- | ||
| General meeting for 2024 | 2025-05-08 15:00 | -- | ||
| Annual report for 2024 | 2025-04-14 | -- | ||
| Second quarter earnings results for 2024 | 2024-08-27 | -- |
Show
Entries
Medlive Technology Co Ltd Frequently Asked Questions
What is Medlive Technology Co Ltd(FRA:1JZ)'s stock price today?
The current price of FRA:1JZ is €0.84. The 52 week high of FRA:1JZ is €0.86 and 52 week low is €0.70.
When is next earnings date of Medlive Technology Co Ltd(FRA:1JZ)?
The next earnings date of Medlive Technology Co Ltd(FRA:1JZ) is 2026-08-27 Est..
Does Medlive Technology Co Ltd(FRA:1JZ) pay dividends? If so, how much?
Medlive Technology Co Ltd(FRA:1JZ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medlive Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers